Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: What is the evidence?
Neural Regeneration Research, ISSN: 1876-7958, Vol: 19, Issue: 3, Page: 536-541
2024
- 2Citations
- 12Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations2
- Citation Indexes2
- Captures12
- Readers12
- 12
- Mentions1
- News Mentions1
- 1
Most Recent News
Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: what is the evidence?
Neural Regen Res. 2024 Mar;19(3):536-541. Authors: Jourdi G, Fleury S, Boukhatem I, Lordkipanidzé M PubMed: 37721281 Submit Comment
Review Description
Neurodegenerative diseases are often misdiagnosed, especially when the diagnosis is based solely on clinical symptoms. The p75 neurotrophic receptor (p75 NTR) has been studied as an index of sensory and motor nerve development and maturation. Its cleavable extracellular domain (ECD) is readily detectable in various biological fluids including plasma, serum and urine. There is evidence for increased p75 NTR ECD levels in neurodegenerative diseases such as Alzheimer's disease, amyotrophic lateral sclerosis, age-related dementia, schizophrenia, and diabetic neuropathy. Whether p75 NTR ECD could be used as a biomarker for diagnosis and/or prognosis in these disorders, and whether it could potentially lead to the development of targeted therapies, remains an open question. In this review, we present and discuss published studies that have evaluated the relevance of this emerging biomarker in the context of various neurodegenerative diseases. We also highlight areas that require further investigation to better understand the role of p75 NTR ECD in the clinical diagnosis and management of neurodegenerative disorders.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85169604545&origin=inward; http://dx.doi.org/10.4103/1673-5374.380873; http://www.ncbi.nlm.nih.gov/pubmed/37721281; https://journals.lww.com/10.4103/1673-5374.380873; http://sciencechina.cn/gw.jsp?action=cited_outline.jsp&type=1&id=7667888&internal_id=7667888&from=elsevier; https://dx.doi.org/10.4103/1673-5374.380873; https://journals.lww.com/nrronline/fulltext/2024/03000/soluble_p75_neurotrophic_receptor_as_a_reliable.25.aspx
Medknow
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know